Polypharmacy in psychiatric practice in the Canary Islands

BMC Psychiatry

Volumn 4, Issue , 2004, Pages

  De las Cuevas, Carlos ^a   Sanz, Emilio J ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Monotherapy; Polypharmacy; Psychiatric patients; Psychotropic drugs

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG CLASSIFICATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; MENTAL DISEASE; MENTAL HEALTH SERVICE; MENTAL PATIENT; MONOTHERAPY; MULTIPLE REGRESSION; POLYPHARMACY; PREDICTION; PRESCRIPTION; PREVALENCE; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SPAIN; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG COMBINATION; MIDDLE AGED; REGRESSION ANALYSIS; STATISTICS;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DATABASES AS TOPIC; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYPHARMACY; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS; RISK ASSESSMENT; SPAIN;

EID: 12944288023     PISSN: 1471244X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-244X-4-18     Document Type: Article

References (31)

1. Berube MS, Neely DJ, DeVinne PB: American Heritage Dictionary. 2nd edition. Boston: Houghton Mifflin Co; 1982.
2. Werder SF, Preskorn SH: Managing polypharmacy: Walking the fine line between help and harm. Current Psychiatry Online 2003, 2(2):.
3. Friend DG: Polypharmacy: multiple-ingredient and shotgun prescriptions. N Engl J Med 1959, 260(20):1015-8.
4. Sheppard C, Collins L, Fiorentino D, Fracchia J, Merlis S: Polypharmacy in psychiatric treatment. I. Incidence at a state hospital. Curr Ther Res Clin Exp 1969, 12:765-74.
5. Stahl SM: Antipsychotic polypharmacy: evidence based or eminence based? Acta Psychiatr Scand 2002, 106:321-322.
6. National Association of State Mental Health Program Directors: Technical Report on Psychiatric Polypharmacy. Medical Directors Council and State Medicaid Directors Alexandria, Virginia; 2001.
7. Rascati K: Drug utilization review of concomitant use of specific serotonine reuptake inhibitors or clomipramine and antianxiety/sleep medications. Clin Ther 1995, 17:786-790.
8. Tanaka E, Hiswa S: Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharm Ther 1999, 24:7-16.
9. Murray M, Kroenke K: Polypharmacy and medication adherence: Small steps on a long road. J Gen Intern Med 2001, 16:137-9.
10. Stahl SM: Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry 2002, 63(2):93-4.
11. OMI-AP (Oficina Médica Informatizada de Atención Primaria) (Primary Care Computerized Medical Office). STACKSCIS Ltd (STACKS Consulting and Software Engineering Ltd.). OMI-AP is a program for the integrated management of primary care consulting medical offices, keeping medical and therapeutical records of individual patients and giving administrative and epidemiological data. [http://www.stacks.es/web_stacks/prod13.htm]
12. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines World Health Organization, Geneva; 1992.
13. Kendell R, Jablensky A: Distinguishing Between the Validity and Utility of Psychiatric Diagnoses. Am J Psychiatry 2003, 160:4-12.
14. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders fourth edition. American Psychiatric Association, Washington DC; 1994.
15. Rittmannsberger H: The use of drug monotherapy in psychiatric inpatient treatment. Progress in Neuro-psychopharmacology & Biological Psychiatry 2002, 26: 47-551.
16. Kapur S: Polypharmacy-in-a-Pill: A Scientific Advance or Are We Making a Virtue of Our Necessities? MedGenMed 2001, 3(2):.
17. Avorn J, Chen M, Hartley R: Scientific versus commercial sources of influence on the prescribing behaviour of physicians. Am J Med 1982, 73:4-8.
18. Wazana A: Physicians and the Pharmaceutical Industry: Is a gift ever just a gift? JAMA 2000, 3:.
19. De las Cuevas C, Sanz E, De la Fuente J: Variations in Antidepressant Prescribing Practice. ¿Clinical Need or Market Influences? Pharmacoepidemiol Drug Saf 2002, 11:515-522.
20. De las Cuevas C, Sanz E: Do therapeutic indications of antidepressants change from one year to another? Pharmacoepidemiol Drug Saf 2004, 13(5):309-314.
21. Harris CM, Heywood PL, Clayden AD: The Analysis of Prescribing in General Practice: A Guide to Audit and Research HSMO: London; 1990.
22. Helman CG: 'Tonic', 'fuel' and 'food': social and symbolic aspects of the long-term use of psychotropic drugs. Soc Sci Med 1981, 15(4):521-33.
23. Christensen RC: The Ethics of Cost Shifting in Community Psychiatry. Psychiatr Serv 2002, 253:921.
24. Bjerrum L, Rosholm JU, Hallas J, Kragstrup J: Methods of estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology 1997, 53(1):7-11.
25. Veehof LJG, Stewart BE, Haaijier-Ruskamp FM, Meyboom-de Jong B: The development of polypharmacy: A longitudinal study. Family Practice 2000, 17:261-267.
26. Rittmannsberger H, Meise U, Schauflinger K, Horvath E, Donat H, Hinterhuber H: Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999, 14(1):33-40.
27. De las Cuevas C, Sanz EJ, De la Fuente J, Cabrera C, Mateos A: Prescribed Daily Doses and "Risk Factors" Associated with the Use of Benzodiazepines in Primary Care. Pharmacoepidemiol Drug Saf 1999, 8(3):207-216.
28. De las Cuevas C, Sanz EJ, Morán N, De la Fuente J: Benzodiazepine Prescription is Different in the Public and Private Sectors. Pharmacoepidemiol Drug Saf 1999, 8(5):351-353.
29. McMillan DA, Harrison PM, Rogers LJ, Tong N, McLean AJ: Polypharmacy in an Australian teaching hospital. Preliminary analysis of prevalence, types of drugs and associations. Med J Aust 1986, 145:339-342.
30. Nolan L, O'Malley K: Prescribing for the elderly: Part II. Prescribing patterns: differences due to age. J Am Geriatr Soc 1988, 36:245-254.
31. Bjerrum L: Pharmacoepidemiological Studies of Polypharmacy: Methodological issues, population estimates, and influence of practice patterns. PhD Thesis Research Unit of General Practice and Department of Clinical Pharmacology The Faculty of Health Sciences Odense University Denmark; 1998.